uploads/2018/02/Consumer-1-2.png

Update on JNJ’s Consumer Products: Baby Care, Beauty, and Oral Care

By

Updated

Baby Care revenue trends

In 2017, Johnson & Johnson’s (JNJ) Baby Care segment generated revenues of $1.9 billion, which reflected an ~4.2% decline on a year-over-year (or YoY) basis. In the US market and the international markets, the Baby Care segment generated 2017 revenues of $449.0 million and $1.5 billion, respectively, compared to $488.0 million and $1.5 billion in 2016.

In 4Q17, JNJ’s Baby Care segment reported revenues of $490.0 million, which is an 1.0% decline on a YoY basis. In 4Q17, the Baby Care segment reported revenues of $123.0 million and $367.0 million, respectively, in the US market and international markets.

In 4Q17, the geographic expansion of Aveeno, a baby care product, partially counterbalanced the competitive pressure in the baby care market.

Article continues below advertisement

Beauty Products revenue trends

In 2017, JNJ’s Beauty Products segment reported revenues of $4.2 billion, which reflected ~7.8% growth on a YoY basis. In the US and international markets, JNJ’s Beauty products reported revenues of $2.3 billion and $1.9 billion, respectively, in 2017, compared to $2.1 billion and $1.8 billion in 2016.

In 4Q17, Johnson & Johnson’s Beauty Products segment reported revenues of $1.1 billion, which is ~4.4% growth on a YoY basis. In 4Q17, in the US and international markets, the Beauty Products segment reported revenues of $596.0 million and $514.0 million, respectively, compared to $580.0 million and $483.0 million in 4Q16.

The growth in sales of Dr. Ci Labo, OGx, and Maui Moisture, along with the growth of e-commerce, primarily contributed to the revenue growth of JNJ’s Beauty Products segment.

Oral Care revenue trends

In fiscal 2017, Johnson & Johnson’s Oral Care segment reported revenues of ~$1.5 billion, which reflected an ~2.4% YoY decline. In 2017, in the US market and international markets, the Oral Care segment reported revenues of $616.0 million and $915.0 million, respectively, compared to $648.0 million and $920.0 million in 2016.

In 4Q17, the Oral Care segment reported revenues of $156.0 million and $237.0 million from the US and international markets, respectively. Its net Oral Care revenues were ~$1.1 billion.

Among Johnson & Johnson’s peers in the baby care and beauty products space, Proctor & Gamble (PG) reported revenues of $17.3 billion in 2Q18. Among Johnson & Johnson’s peers in the baby care market, Kimberly-Clark (KMB) and Novartis (NVS) reported revenues of $4.6 billion and $12.9 billion, respectively, in 4Q17.

Advertisement

More From Market Realist